Davy Beauger1, Dorothée Fruit2,3,4, Claire Villeneuve2,3, Marie-Laure Laroche2,4, Elisabeth Jouve5, Annick Rousseau3,6, Laurent Boyer7, Stéphanie Gentile7. 1. EA 3279 - Public Health, Chronic Diseases and Quality of Life - Research Unit, Aix-Marseille University, 13005, Marseille, France. davy.beauger@ap-hm.fr. 2. Department of Pharmacology, Toxicology and Centre of Pharmacovigilance, CHU Limoges, Limoges, France. 3. INSERM, UMR-S850, Limoges, France. 4. Faculty of Medicine, Laboratory of Clinical Pharmacology, Univ Limoges, Limoges, France. 5. Medical Evaluation and Public Health Department, Assistance Publique - Hôpitaux de Marseille, Marseille, France. 6. Faculty of Pharmacy, Department of Biophysics, Univ Limoges, Limoges, France. 7. EA 3279 - Public Health, Chronic Diseases and Quality of Life - Research Unit, Aix-Marseille University, 13005, Marseille, France.
Abstract
BACKGROUND: Renal transplantation is considered as the treatment of choice for patients with end-stage renal disease. Health-related quality of life (HRQoL) of renal transplant recipients (RTR) is very important to assess, especially during the first year after transplantation. To provide new evidence about the suitability of HRQoL measures in RTR during the first post-transplant year, we explored the internal structure, reliability and external validity of a French specific HRQoL instrument, the Renal Transplant Quality of life Questionnaire Second Version (RTQ V2). METHODS: The data were issued from the French multicenter cohort of renal transplant patients followed during 4 years (EPIGREN). The HRQoL of RTR was assessed five times (at 1, 3, 6, 9 and 12 months after transplantation) with the RTQ V2, a specific instrument consisting of 32 items describing five dimensions. Socio-demographic information, clinical characteristics and HRQoL (i.e., RTQ V2 and SF-36) were collected. For the five times, psychometric properties of the RTQ V2 were compared to those reported from the reference population assessed in the validation study. RESULTS: Three hundred and thirty-four patients were enrolled. The proportions of well-projected items, item-internal consistency, item-discriminant validity, floor and ceiling effects, Cronbach's alpha coefficients and item goodness-of-fit statistics were satisfactory for each dimension at the five times of the study. The suitability indices of construct validity were higher than 90 % for each time (minimum-maximum: 90.8-97.4 %). The external validity was less satisfactory, with a suitability indices ranged from 46.7 % at M1 to 66.7 % at M12. However, the discrepancies with the reference population (mainly for the gender) appeared logical considering the scientific literature on HRQoL of RTR during the first post-transplant year and may not compromise the external validity. CONCLUSION: These results support the validity and reliability of the RTQ V2 for evaluating HRQoL in RTR during the first post-transplant year, and confirm that the RTQ V2 is a useful tool to assess the HRQoL precociously after transplant.
BACKGROUND: Renal transplantation is considered as the treatment of choice for patients with end-stage renal disease. Health-related quality of life (HRQoL) of renal transplant recipients (RTR) is very important to assess, especially during the first year after transplantation. To provide new evidence about the suitability of HRQoL measures in RTR during the first post-transplant year, we explored the internal structure, reliability and external validity of a French specific HRQoL instrument, the Renal Transplant Quality of life Questionnaire Second Version (RTQ V2). METHODS: The data were issued from the French multicenter cohort of renal transplant patients followed during 4 years (EPIGREN). The HRQoL of RTR was assessed five times (at 1, 3, 6, 9 and 12 months after transplantation) with the RTQ V2, a specific instrument consisting of 32 items describing five dimensions. Socio-demographic information, clinical characteristics and HRQoL (i.e., RTQ V2 and SF-36) were collected. For the five times, psychometric properties of the RTQ V2 were compared to those reported from the reference population assessed in the validation study. RESULTS: Three hundred and thirty-four patients were enrolled. The proportions of well-projected items, item-internal consistency, item-discriminant validity, floor and ceiling effects, Cronbach's alpha coefficients and item goodness-of-fit statistics were satisfactory for each dimension at the five times of the study. The suitability indices of construct validity were higher than 90 % for each time (minimum-maximum: 90.8-97.4 %). The external validity was less satisfactory, with a suitability indices ranged from 46.7 % at M1 to 66.7 % at M12. However, the discrepancies with the reference population (mainly for the gender) appeared logical considering the scientific literature on HRQoL of RTR during the first post-transplant year and may not compromise the external validity. CONCLUSION: These results support the validity and reliability of the RTQ V2 for evaluating HRQoL in RTR during the first post-transplant year, and confirm that the RTQ V2 is a useful tool to assess the HRQoL precociously after transplant.
Entities:
Keywords:
Kidney transplantation; Psychometrics; Quality of Health Care; Quality of life; Questionnaires
Authors: Jaroslav Rosenberger; Jitse P van Dijk; Iveta Nagyova; Ivan Zezula; Andrea Madarasova Geckova; Robert Roland; Wim J A van den Heuvel; Johan W Groothoff Journal: Transplantation Date: 2006-05-15 Impact factor: 4.939
Authors: Arthur J Matas; R J Halbert; Mark L Barr; J Harold Helderman; Donald E Hricik; John D Pirsch; Felicia A Schenkel; Bonita R Siegal; Honghu Liu; Ronald M Ferguson Journal: Clin Transplant Date: 2002-04 Impact factor: 2.863
Authors: T Ortega; R Deulofeu; P Salamero; A Roman; N Masnou; S Rubio; O Garcia; T Casanovas; F Cofán; J Twose; F Ortega Journal: Transplant Proc Date: 2009 Jul-Aug Impact factor: 1.066